Hair loss troubles hundreds of millions of people worldwide. Hair regrowth technologies keep evolving from traditional medication therapy to the emerging microneedle therapy. In recent years, the application of household microneedle devices in hair loss treatment has gained increasing attention, and many hair loss sufferers have begun trying self-administered microneedle therapy at home. The feasibility, efficacy and safety of this treatment method deserve in-depth discussion.

Mechanism and Professional Application of Microneedling for Hair Loss

The principle of microneedling for hair loss relies on the dual effects of wound repair mechanism and enhanced drug permeation. When microneedles penetrate the scalp, they create hundreds of micron-scale microchannels in the epidermis. Such micro-injuries stimulate the scalp to initiate the repair process, boost local blood circulation, activate hair follicle stem cells, and increase the release of growth factors. Meanwhile, the formation of microchannels significantly improves the transdermal absorption rate of topical medications, enabling hair regrowth drugs such as minoxidil to reach hair follicles more effectively.

Issued in February 2025 by the Chinese Journal of Medical Aesthetics and Cosmetology, the Expert Consensus on Clinical Application of Microneedles in Hair Regeneration is currently one of the most authoritative domestic guidelines on microneedle therapy for hair loss. The consensus points out that when operated correctly, microneedle therapy causes almost no adverse effects on the body and is theoretically suitable for all hair loss patients. It is especially ideal for patients with moderate to severe hair loss (Grade 4 baldness or above, or overall scalp thinning). Microneedling does not conflict with other therapies (medication, laser, PRP, traditional Chinese medicine, etc.) and can even amplify the efficacy of other treatments.

In professional medical institutions, microneedle therapy for hair loss has formed a standardized operating procedure. Electric microneedles of 0.5–2.5 mm or roller microneedles of 1.5–2.0 mm are recommended. In terms of treatment frequency, once a week or once every two weeks is suggested in the initial stage, with adjustments made according to individual conditions. For operation techniques, pen-type microneedles adopt linear lifting and dotting movements, while roller microneedles follow a cross-shaped rolling pattern. The appropriate endpoint is slight erythema or pinpoint bleeding; mild oozing is acceptable, yet heavy bleeding is not recommended.

Current Situation and Risks of At-Home Microneedling for Hair Loss

With the popularization of microneedle technology, a growing number of hair loss patients attempt self-treatment at home. Medical-grade microneedle products of various prices sell well on e-commerce platforms, with buyers commenting that such scalp medication application tools are "slightly prickle but completely tolerable". Nevertheless, this self-treatment model at home carries significant hidden risks.

Dr. Li Zhenjie, Chief Physician and Director of the Hair Loss Specialist Clinic at Guangzhou Municipal Dermatology Hospital, states that although many hair loss patients do use microneedles for self-treatment at home, microneedling is not suitable for everyone, and standardized treatment under medical guidance is strongly recommended. The main risks of at-home operation are as follows:

Risk of infection: Household environments cannot meet medical-grade sterile standards. The scalp is rich in hair follicles and sebaceous glands, serving as a breeding ground for bacteria. Incomplete disinfection after microneedle penetration can easily trigger folliculitis, scalp infection and other complications.

Injury caused by improper operation: The scalp varies in thickness and curvature across different regions. Non-professionals struggle to grasp the appropriate penetration depth and angle. Excessive penetration may damage hair follicles and aggravate hair loss instead; insufficient penetration fails to achieve therapeutic effects.

Product selection concerns: Commercially available household microneedle products vary greatly in quality, with unguaranteed needle material, sharpness and sterilization status. Some products may contain harmful substances or feature poorly designed needle structures, further raising treatment risks.

Improper control of treatment frequency: Professional treatment generally recommends an interval of 4–6 weeks. In contrast, household users may over-treat out of eagerness for results, damaging the scalp barrier and triggering inflammatory reactions.